Product Description
Known For: Philadelphia’s first psychedelic-assisted psychotherapy center, founded as a 501(c)(3) nonprofit by Dr. Hannah McLane. Known for its cohort-based KAP model that pairs oral ketamine with deep psychoanalytic preparation and integration work.
| Review Scores | Highly regarded; patients praise the depth and intentionality of the therapeutic model |
| Location | Philadelphia, PA |
| Address | 4623 Spruce Street, Philadelphia, PA 19139 |
| Phone | Contact via website |
| Website | soundmind.center |
| Treatments | Ketamine-Assisted Psychotherapy (KAP), Oral Ketamine Lozenges, Breathwork, Integration Therapy |
| Conditions Treated | Treatment-Resistant Depression, PTSD, Trauma, Anxiety, End-of-Life Distress |
| Cost | Contact for pricing; cohort-based enrollment model |
| Insurance | Not accepted for ketamine services |
| KAP Available? | Yes — core offering with deep therapeutic integration |
| Clinical Lead | Dr. Hannah McLane, MD — Physician, Psychoanalyst (Brown/Harvard-trained) |
HealingMaps Take: SoundMind is not a ketamine clinic in the traditional sense — it is a psychedelic therapy center that happens to use ketamine as its primary legal tool. Founded by Dr. Hannah McLane, a Brown and Harvard-trained physician and psychoanalyst, the center operates as a 501(c)(3) nonprofit with a mission that prioritizes therapeutic depth over volume. Patients enroll in cohorts (typically April and September), creating a community-based structure that is unusual in this space. Each session includes extensive preparation, a 2-3 hour guided oral ketamine experience, and structured integration. This is the polar opposite of a drive-through infusion model. The nonprofit structure means SoundMind is not optimizing for margins, and the cohort model means they are intentionally limiting access to maintain therapeutic quality. For patients seeking the deepest possible therapeutic work with ketamine — particularly trauma survivors — this is one of the most thoughtful programs in the region.
Patient Review
“SoundMind’s approach is deeply intentional. The preparation and integration work made the ketamine sessions far more meaningful than just an infusion. Dr. McLane’s team creates a genuinely safe space for the hardest therapeutic work I have ever done.”
About SoundMind Center
SoundMind Center is a 501(c)(3) nonprofit psychedelic-assisted psychotherapy center located at 4623 Spruce Street in West Philadelphia. Founded by Dr. Hannah McLane, a Brown and Harvard-trained physician and relational psychoanalyst, SoundMind launched in 2021 as Philadelphia’s first psychedelic therapy center. The center offers ketamine-assisted psychotherapy (KAP) using oral ketamine lozenges paired with deep psychotherapeutic preparation and integration. Patients enroll in cohorts, creating a community-based treatment structure. SoundMind also operates training programs for psychedelic facilitators and retreat offerings in Oregon and Costa Rica.
For more on how ketamine therapy works, see our complete guide to ketamine therapy.
What People Like
Nonprofit model means patient outcomes are prioritized over revenue. Dr. McLane’s Brown/Harvard training and psychoanalytic background bring exceptional clinical depth. Cohort-based enrollment creates community support among patients. 2-3 hour guided sessions with full preparation and integration — not a quick infusion. Philadelphia’s first and most established psychedelic therapy center. Training programs signal institutional seriousness about the field.
What People Don’t Like
Cohort enrollment limits when patients can start treatment (typically April and September). No IV ketamine — oral lozenges only. Insurance not accepted. Phone number not prominently listed — contact is primarily through the website. Not suitable for patients seeking rapid, on-demand ketamine infusions for acute crisis.
Getting Started at SoundMind Center
Visit soundmind.center to learn about upcoming cohort enrollment periods. The center is at 4623 Spruce Street, Philadelphia, PA 19139. SoundMind enrolls patients in cohorts, so plan ahead — check the website for the next available start date.
Learn more about the evidence behind ketamine for depression at the National Institute of Mental Health.


Reviews
There are no reviews yet.